Natixis Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $75.5M | Sell |
195,156
-16,008
| -8% | -$5.94M | 0.08% | 211 |
|
|
2026
Q1 | $61.8M | Sell |
211,164
-55,898
| -21% | -$18.4M | 0.09% | 228 |
|
|
2025
Q4 | $93.6M | Buy |
267,062
+22,267
| +9% | +$7.52M | 0.13% | 161 |
|
|
2025
Q3 | $79.1M | Buy |
244,795
+54,738
| +29% | +$17M | 0.12% | 184 |
|
|
2025
Q2 | $73.9M | Buy |
190,057
+24,513
| +15% | +$9.86M | 0.12% | 188 |
|
|
2025
Q1 | $72M | Buy |
165,544
+42,114
| +34% | +$16.9M | 0.13% | 171 |
|
|
2024
Q4 | $45.5M | Sell |
123,430
-68,666
| -36% | -$28.7M | 0.09% | 238 |
|
|
2024
Q3 | $99.9M | Buy |
192,096
+14,502
| +8% | +$7.75M | 0.19% | 114 |
|
|
2024
Q2 | $96.2M | Buy |
177,594
+5,662
| +3% | +$2.99M | 0.21% | 106 |
|
|
2024
Q1 | $89.2M | Buy |
171,932
+11,209
| +7% | +$5.57M | 0.21% | 110 |
|
|
2023
Q4 | $75.8M | Buy |
160,723
+17,799
| +12% | +$8.23M | 0.2% | 122 |
|
|
2023
Q3 | $62.2M | Buy |
142,924
+11,067
| +8% | +$5.02M | 0.19% | 120 |
|
|
2023
Q2 | $58.6M | Sell |
131,857
-31,490
| -19% | -$14.5M | 0.18% | 135 |
|
|
2023
Q1 | $75.1M | Sell |
163,347
-3,897
| -2% | -$1.85M | 0.26% | 98 |
|
|
2022
Q4 | $85.8M | Sell |
167,244
-18,953
| -10% | -$9.62M | 0.32% | 82 |
|
|
2022
Q3 | $84.6M | Buy |
186,197
+9,141
| +5% | +$4.37M | 0.36% | 62 |
|
|
2022
Q2 | $85.4M | Buy |
177,056
+1,571
| +0.9% | +$777K | 0.38% | 63 |
|
|
2022
Q1 | $86.2M | Buy |
175,485
+9,412
| +6% | +$4.3M | 0.33% | 68 |
|
|
2021
Q4 | $77M | Buy |
166,073
+9,077
| +6% | +$3.82M | 0.29% | 74 |
|
|
2021
Q3 | $58.5M | Sell |
156,996
-731
| -0.5% | -$278K | 0.24% | 90 |
|
|
2021
Q2 | $60.2M | Buy |
157,727
+5,918
| +4% | +$2.26M | 0.28% | 75 |
|
|
2021
Q1 | $54.5M | Buy |
151,809
+4,657
| +3% | +$1.5M | 0.28% | 74 |
|
|
2020
Q4 | $47.2M | Buy |
147,152
+6,977
| +5% | +$2.14M | 0.27% | 78 |
|
|
2020
Q3 | $37.6M | Buy |
140,175
+592
| +0.4% | +$159K | 0.24% | 95 |
|
|
2020
Q2 | $36.7M | Buy |
139,583
+12,878
| +10% | +$3.44M | 0.24% | 91 |
|
|
2020
Q1 | $28.8M | Buy |
126,705
+14,797
| +13% | +$4.03M | 0.23% | 95 |
|
|
2019
Q4 | $33.8M | Buy |
111,908
+14,752
| +15% | +$4.06M | 0.24% | 88 |
|
|
2019
Q3 | $23.3M | Sell |
97,156
-18,481
| -16% | -$5.06M | 0.19% | 132 |
|
|
2019
Q2 | $32.6M | Buy |
115,637
+17,439
| +18% | +$4.76M | 0.27% | 84 |
|
|
2019
Q1 | $28.2M | Sell |
98,198
-5,675
| -5% | -$1.64M | 0.25% | 90 |
|
|
2018
Q4 | $27.3M | Buy |
103,873
+2,670
| +3% | +$734K | 0.27% | 79 |
|
|
2018
Q3 | $27.7M | Sell |
101,203
-14,852
| -13% | -$3.86M | 0.24% | 84 |
|
|
2018
Q2 | $27.6M | Buy |
116,055
+2,479
| +2% | +$574K | 0.26% | 81 |
|
|
2018
Q1 | $25M | Buy |
113,576
+1,570
| +1% | +$369K | 0.25% | 81 |
|
|
2017
Q4 | $25.2M | Sell |
112,006
-2,264
| -2% | -$482K | 0.26% | 73 |
|
|
2017
Q3 | $21.7M | Sell |
114,270
-1,289
| -1% | -$245K | 0.23% | 89 |
|
|
2017
Q2 | $21.7M | Sell |
115,559
-46,917
| -29% | -$8.43M | 0.24% | 84 |
|
|
2017
Q1 | $26.9M | Sell |
162,476
-6,567
| -4% | -$1.04M | 0.3% | 61 |
|
|
2016
Q4 | $24.3M | Buy |
169,043
+1,409
| +0.8% | +$189K | 0.29% | 70 |
|
|
2016
Q3 | $21M | Sell |
167,634
-1,695
| -1% | -$219K | 0.27% | 77 |
|
|
2016
Q2 | $22.2M | Buy |
169,329
+12,818
| +8% | +$1.75M | 0.31% | 70 |
|
|
2016
Q1 | $21.8M | Buy |
156,511
+101,608
| +185% | +$13.6M | 0.33% | 62 |
|
|
2015
Q4 | $7.66M | Buy |
54,903
+3,638
| +7% | +$501K | 0.13% | 206 |
|
|
2015
Q3 | $7.18M | Sell |
51,265
-5,358
| -9% | -$805K | 0.12% | 214 |
|
|
2015
Q2 | $9.29M | Sell |
56,623
-2,377
| -4% | -$380K | 0.16% | 170 |
|
|
2015
Q1 | $9.11M | Buy |
59,000
+20,062
| +52% | +$2.86M | 0.16% | 155 |
|
|
2014
Q4 | $4.89M | Sell |
38,938
-3,117
| -7% | -$385K | 0.09% | 337 |
|
|
2014
Q3 | $5.03M | Buy |
42,055
+10,186
| +32% | +$1.17M | 0.1% | 311 |
|
|
2014
Q2 | $3.43M | Buy |
31,869
+4,650
| +17% | +$479K | 0.05% | 547 |
|
|
2014
Q1 | $2.71M | Sell |
27,219
-707
| -3% | -$63.9K | 0.04% | 564 |
|
|
2013
Q4 | $2.58M | Buy |
27,926
+2,631
| +10% | +$234K | 0.04% | 554 |
|
|
2013
Q3 | $2.12M | Sell |
25,295
-6,163
| -20% | -$528K | 0.04% | 563 |
|
|
2013
Q2 | $2.57M | Buy |
+31,458
| New | +$2.35M | 0.05% | 498 |
|
Other funds holding ELV
Natixis Advisors's ELV Position: Q2 2026 in Review
Natixis Advisors reduced its Elevance Health (ELV) stake by 7.6% in Q2 2026, selling an estimated $5.94M and leaving 195,156 shares worth $75.5M. The position accounts for 0.08% of the portfolio, ranked #211.
Natixis Advisors first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $99.9M in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Natixis Advisors held 195,156 shares of Elevance Health worth $75.5M as of Q2 2026.
- Natixis Advisors sold 16,008 Elevance Health shares in Q2 2026, an estimated $5.94M.
- Elevance Health made up 0.08% of Natixis Advisors's portfolio in Q2 2026, its #211 holding.
- Natixis Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Natixis Advisors's Elevance Health position peaked at $99.9M in Q3 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.